Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TVRD
$1.88
+7.74%
TVRD
· Tvardi Therapeutics, Inc.
$1.88
+0.14 (+7.74%)
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$24.54M
Shares
13.34M
All earnings calls
Earnings call · FY2020 Q3
Tvardi Therapeutics, Inc. (TVRD) Q3 2020 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$9.27M
+60.2% YoY
Diluted EPS
-$12.60
Net income
-$16.51M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2020 · complete as-filed document